J&J denies class action’s claims that it sold ineffective cold meds

Class Actions 2025-10-01 11:45 pm | Sydney
Pharmaceutical giant Johnson & Johnson has denied knowingly selling alleged ineffective medications under its Benadryl, Sudafed and Codral brands, saying research indicated the phenylephrine-containing products worked.
For information on rights and reprints, contact subscriptions@lawyerly.com.au